FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Pre-submission and Q-Submission meetings apparently have been halted, for now
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
UDT false billing cases seem to be on the rise again, accounting for a trio of recent multimillion dollar settlements.
On April 11, the OIG approved a proposed arrangement involving the offering of free genetic tests and counseling services.
Counterfeit COVID-19 tests are being illegally imported into the US and being distributed to unsuspecting consumers across the country.
A briefing on how labs should prepare for the inevitable end of the PHE after more than two years of unprecedented relief.
In this month’s Business Roundup, we cover key happenings including Medicare coverage and reimbursement, as well as the US surpassing Europe as medtech’s market of choice.
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
The HHS recently published previously confidential data relating to consolidation of hospitals and nursing homes enrolled in Medicare.